SEC Form 4 · accession 0001209191-15-023585
Endo International plc · ENDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Lortie
Officer — President Branded Pharma
Period of report
Mar 4, 2015
Accepted (ET)
Mar 6, 2015 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001593034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Mar 4, 2015 | S | 5,800 | $85.35 | D | 16,784 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 4, 2015, Mr. Lortie sold 5,800 ordinary shares relating to vested restricted stock units and performance shares.
- F2This represents the average price at which Mr. Lortie's ordinary shares were sold on March 4, 2015.